Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...
Read Full NewsA study of nearly 1 million veterans suggests that simpler lung cancer screening eligibility — based on smoking duration — would sharply reduce missed cancers and narrow disparities.
A large population study of young Black women aged 50 years or younger with invasive breast cancer highlights the importance of genetic testing in this population.
Eligible men with early prostate cancer can now be offered a high-precision radiotherapy technique on the NHS in England.
1.
Check for eating disorders in bipolar disorder patients.
2.
Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes
3.
Decrease seen in in situ breast cancer since 2009
4.
Racial differences seen in epigenetic age acceleration in childhood cancer survivors
5.
Housing aid linked to lower medical financial hardship among US renters with cancer
1.
ADCs and Bispecific Antibodies: Advancing the Future of Cancer Immunotherapy
2.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
3.
Mapping Gene Expression in Tumors: The Emerging Role of Spatial Transcriptomics
4.
Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans
5.
Gene Signatures and Their Implications in Oncology: Decoding the Blueprint for Personalized Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
3.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge